Correlation Between Acumen Pharmaceuticals and Anheuser Busch
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Anheuser Busch at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Anheuser Busch into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Anheuser Busch Inbev, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Anheuser Busch and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Anheuser Busch. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Anheuser Busch.
Diversification Opportunities for Acumen Pharmaceuticals and Anheuser Busch
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Acumen and Anheuser is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Anheuser Busch Inbev in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anheuser Busch Inbev and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Anheuser Busch. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anheuser Busch Inbev has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Anheuser Busch go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and Anheuser Busch
Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 3.81 times more return on investment than Anheuser Busch. However, Acumen Pharmaceuticals is 3.81 times more volatile than Anheuser Busch Inbev. It trades about -0.01 of its potential returns per unit of risk. Anheuser Busch Inbev is currently generating about -0.09 per unit of risk. If you would invest 275.00 in Acumen Pharmaceuticals on September 1, 2024 and sell it today you would lose (48.00) from holding Acumen Pharmaceuticals or give up 17.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Acumen Pharmaceuticals vs. Anheuser Busch Inbev
Performance |
Timeline |
Acumen Pharmaceuticals |
Anheuser Busch Inbev |
Acumen Pharmaceuticals and Anheuser Busch Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acumen Pharmaceuticals and Anheuser Busch
The main advantage of trading using opposite Acumen Pharmaceuticals and Anheuser Busch positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Anheuser Busch can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anheuser Busch will offset losses from the drop in Anheuser Busch's long position.Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
Anheuser Busch vs. Boston Beer | Anheuser Busch vs. Molson Coors Beverage | Anheuser Busch vs. Heineken NV | Anheuser Busch vs. Ambev SA ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |